{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:07:19Z","timestamp":1778947639423,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lfs.2026.124369","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:46:58Z","timestamp":1775231218000},"page":"124369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Valsartan promotes neuroprotection in Parkinson's disease via epigenetic modulation and activation of the ASCL1\/Nurr1 pathway"],"prefix":"10.1016","volume":"394","author":[{"given":"Hadeer G.","family":"Gowied","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrine S.","family":"El-Mezayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham A.","family":"Afify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124369_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","article-title":"Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease","volume":"18","author":"Lee","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2026.124369_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70540","article-title":"Parkinson\u2019s disease: the epidemiology, risk factors, molecular pathogenesis, prevention, and therapy","volume":"6","author":"Guo","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.lfs.2026.124369_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.lfs.2026.124369_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.20517\/2347-8659.2020.58","article-title":"A review on Parkinson's disease treatment","volume":"8","author":"Lee","year":"2021","journal-title":"Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.lfs.2026.124369_bb0025","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/syn.20686","article-title":"Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals","volume":"63","author":"Qi","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.lfs.2026.124369_bb0030","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1096\/fasebj.4.10.2197154","article-title":"Dopamine receptors and transporters in Parkinson's disease and schizophrenia","volume":"4","author":"Seeman","year":"1990","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2026.124369_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2011.06.051","article-title":"Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system","volume":"1408","author":"Anderson","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2026.124369_bb0045","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.18632\/oncotarget.6920","article-title":"Aldehyde dehydrogenase 1A1 in stem cells and cancer","volume":"7","author":"Tomita","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2026.124369_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12035-019-01701-x","article-title":"Neuronal trans-differentiation by transcription factors Ascl1 and Nurr1: induction of a dopaminergic neurotransmitter phenotype in cortical GABAergic neurons","volume":"57","author":"Raina","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124369_bb0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","article-title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson\u2019s disease","volume":"77","author":"Jankovic","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124369_bb0060","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.bbamcr.2012.06.030","article-title":"Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability","volume":"1823","author":"van Tiel","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2026.124369_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124369_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature10284","article-title":"Direct generation of functional dopaminergic neurons from mouse and human fibroblasts","volume":"476","author":"Caiazzo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124369_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2015.04.027","article-title":"Neurogenin 2 enhances the generation of patient-specific induced neuronal cells","volume":"1615","author":"Zhao","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0080","article-title":"Histone deacetylases as epigenetic targets for treating parkinson\u2019s disease","volume":"12","author":"Li","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.lfs.2026.124369_bb0085","doi-asserted-by":"crossref","first-page":"14370","DOI":"10.1523\/JNEUROSCI.1155-15.2015","article-title":"Nurr1 and retinoid X receptor ligands stimulate ret signaling in dopamine neurons and can alleviate \u03b1-Synuclein disrupted gene expression","volume":"35","author":"Volakakis","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124369_bb0090","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2165\/11319460-000000000-00000","article-title":"Valsartan: More than a decade of experience","volume":"69","author":"Black","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2026.124369_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2018.05.021","article-title":"Oral vitamin-A-coupled valsartan nanomedicine: high hepatic stellate cell receptors accessibility and prolonged enterohepatic residence","volume":"283","author":"El-Mezayen","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2026.124369_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122939","article-title":"Valsartan as a prophylactic treatment against breast cancer development and niche activation: what molecular sequels follow chronic AT-1R blockade?","volume":"353","author":"Mansour","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2026.124369_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/HJH.0b013e32834000e2","article-title":"Treatment with valsartan stimulates endothelial progenitor cells and renal label-retaining cells in hypertensive rats","volume":"29","author":"Yoshida","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2026.124369_bb0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/jcmm.12251","article-title":"Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity","volume":"18","author":"Shan","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2026.124369_bb0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/wrr.12974","article-title":"Valsartan nano-filaments alter mitochondrial energetics and promote faster healing in diabetic rat wounds","volume":"29","author":"Nidadavolu","year":"2021","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.lfs.2026.124369_bb0120","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3892\/etm.2015.2374","article-title":"Effect of the angiotensin II receptor blocker valsartan on cardiac hypertrophy and myocardial histone deacetylase expression in rats with aortic constriction","volume":"9","author":"Xu","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2026.124369_bb0125","article-title":"Antihypertensive agents and risk of parkinson\u2019s disease: a nationwide cohort study","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124369_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2021.03.007","article-title":"Effects of angiotensin type 1 receptor antagonists on Parkinson\u2019s disease progression: an exploratory study in the PPMI database","volume":"86","author":"Udovin","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2026.124369_bb0135","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/ejn.15222","article-title":"Haloperidol-induced catalepsy as an animal model for parkinsonism: a systematic review of experimental studies","volume":"53","author":"Waku","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124369_bb0140","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/cns.14179","article-title":"Reactive astrocytes targeting with oral vitamin A: efficient neuronal regeneration for Parkinson\u2019s disease treatment and reversal of associated liver fibrosis","volume":"29","author":"El-Mezayen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2026.124369_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.56557\/ajoaims\/2025\/v7i1157","article-title":"Decoding Parkinson\u2019s disease through animal models: mechanistic insights and therapeutic roadmaps","volume":"7","author":"Chandrika","year":"2025","journal-title":"Asian J. Adv. Med. Sci."},{"key":"10.1016\/j.lfs.2026.124369_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2017.00145","article-title":"Effect of levodopa on reward and impulsivity in a rat model of Parkinson\u2019s disease","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.lfs.2026.124369_bb0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1440-1797.2009.01143.x","article-title":"Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model","volume":"14","author":"Tominaga","year":"2009","journal-title":"Nephrology"},{"key":"10.1016\/j.lfs.2026.124369_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00441-016-2553-0","article-title":"Meloxicam medication reduces orthodontically induced dental root resorption and tooth movement velocity: a combined in vivo and in vitro study of dental-periodontal cells and tissue","volume":"368","author":"Kirschneck","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0165","doi-asserted-by":"crossref","first-page":"468","DOI":"10.30802\/AALAS-CM-19-000048","article-title":"Clinical Management of Pain in rodents","volume":"69","author":"Foley","year":"2019","journal-title":"Comp. Med."},{"key":"10.1016\/j.lfs.2026.124369_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s42004-020-0331-0","article-title":"The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs","volume":"3","author":"Willems","year":"2020","journal-title":"Commun. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0175","article-title":"The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson\u2019s disease rat model","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2026.124369_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","article-title":"The open field test for measuring locomotor activity and anxiety-like behavior","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2026.124369_bb0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","article-title":"Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model","volume":"122","author":"Miyanishi","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2026.124369_bb0190","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.lfs.2026.124369_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0488-19.2020","article-title":"An open source automated bar test for measuring catalepsy in rats","volume":"7","author":"Luciani","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.lfs.2026.124369_bb0200","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/phrs.2001.0887","article-title":"Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats","volume":"44","author":"Afify","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0205","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1248\/bpb.b14-00012","article-title":"Inhalation anesthesia is preferable for recording rat cardiac function using an electrocardiogram","volume":"37","author":"Murakami","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2026.124369_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00064","article-title":"\u0391-synuclein negatively regulates Nurr1 expression through NF-\u03baB-related mechanism","volume":"13","author":"Jia","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2026.124369_bb0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2026.124369_bb0220","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.lfs.2026.124369_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0026-265X(78)90034-6","article-title":"Further modification of a fluorometric method for analyzing brain amines","volume":"23","author":"Ciarlone","year":"1978","journal-title":"Microchem. J."},{"key":"10.1016\/j.lfs.2026.124369_bb0230","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/jpet.103.049270","article-title":"Sources and significance of plasma levels of catechols and their metabolites in humans","volume":"305","author":"Goldstein","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2026.124369_bb0235","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1373\/clinchem.2005.051532","article-title":"Enzyme immunoassay (EIA)\/enzyme-linked immunosorbent assay (ELISA)","volume":"51","author":"Lequin","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0240","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251315913","article-title":"An overview of ELISA: a review and update on best laboratory practices for quantifying peptides and proteins in biological fluids","volume":"53","author":"Aydin","year":"2025","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0245","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/1389557516666161025094539","article-title":"Angiotensin mediated oxidative stress and neuroprotective potential of antioxidants and at1 receptor blockers","volume":"17","author":"Prusty","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-022-00544-w","article-title":"The role of NURR1 in metabolic abnormalities of Parkinson\u2019s disease","volume":"17","author":"Al-Nusaif","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2026.124369_bb0255","doi-asserted-by":"crossref","first-page":"29835","DOI":"10.18632\/oncotarget.8104","article-title":"Emerging preclinical pharmacological targets for Parkinson\u2019s disease","volume":"7","author":"More","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2026.124369_bb0260","first-page":"4078","article-title":"Modulatory role of nurr1 activation and thrombin inhibition in the neuroprotective effects of dabigatran etexilate in rotenone-induced parkinson\u2019s disease in rats","volume":"55","author":"Kandil","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124369_bb0265","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cns.12536","article-title":"Nurr1-based therapies for Parkinson\u2019s disease","volume":"22","author":"Dong","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2026.124369_bb0275","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cell.2013.07.001","article-title":"A prolyl-isomerase mediates dopamine-dependent plasticity and cocaine motor sensitization","volume":"154","author":"Park","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124369_bb0280","doi-asserted-by":"crossref","first-page":"21955","DOI":"10.1074\/jbc.M112.444224","article-title":"The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of parkinson disease*","volume":"288","author":"Ghosh","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0285","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12035-020-02179-8","article-title":"The peptidyl-prolyl isomerase Pin1 in neuronal signaling: from neurodevelopment to neurodegeneration","volume":"58","author":"Fagiani","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124369_bb0290","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1074\/jbc.M507026200","article-title":"Prolyl-isomerase pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of \u03b1-synuclein inclusions*","volume":"281","author":"Ryo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.644776","article-title":"Function and regulation of ALDH1A1-positive nigrostriatal dopaminergic neurons in motor control and Parkinson\u2019s disease","volume":"15","author":"Carmichael","year":"2021","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.lfs.2026.124369_bb0300","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1242\/dev.02865","article-title":"Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency","volume":"134","author":"Jacobs","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.lfs.2026.124369_bb0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00702-014-1320-1","article-title":"Aldehyde dehydrogenase (ALDH) in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"123","author":"Gr\u00fcnblatt","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.lfs.2026.124369_bb0310","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/14756366.2011.653353","article-title":"Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening","volume":"28","author":"Kotraiah","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0315","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/1091581812442939","article-title":"Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride\u2013induced rat hepatic injury","volume":"31","author":"Edfawy","year":"2012","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.lfs.2026.124369_bb0320","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/dev.095802","article-title":"Foxa2 acts as a co-activator potentiating expression of the Nurr1-induced DA phenotype via epigenetic regulation","volume":"141","author":"Yi","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.lfs.2026.124369_bb0325","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1242\/dev.075978","article-title":"In vitro generation of mature dopamine neurons by decreasing and delaying the expression of exogenous Nurr1","volume":"139","author":"Park","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.lfs.2026.124369_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114420","article-title":"Histone deacetylase 1 regulates haloperidol-induced motor side effects in aged mice","volume":"447","author":"McClarty","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2026.124369_bb0335","article-title":"Targeting histone deacetylases: a novel approach in Parkinson\u2019s disease","volume":"2015","author":"Sharma","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.lfs.2026.124369_bb0340","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2012.07.001","article-title":"RGFP109, a histone deacetylase inhibitor attenuates l-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study","volume":"19","author":"Johnston","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2026.124369_bb0345","first-page":"175","article-title":"Pro-oxidant and degenerative effects of haloperidol under inflammatory conditions in rat; the involvement of SIRT1 and NF-\u03baB signaling pathways","volume":"12","author":"Bahrambeigi","year":"2021","journal-title":"Vet. Res. Forum."},{"key":"10.1016\/j.lfs.2026.124369_bb0350","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2026.124369_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020168","article-title":"Empagliflozin protects against haloperidol experimentally-induced ovarian toxicity","volume":"16","author":"Abdelzaher","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.lfs.2026.124369_bb0360","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/ijms20081844","article-title":"Expression of longevity genes induced by a low-dose fluvastatin and valsartan combination with the potential to prevent\/treat \u201caging-related disorders\u201d","volume":"20","author":"Jani\u0107","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124369_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118011","article-title":"Combining vinpocetine or cocoa with levodopa, coenzyme Q10 and vitamin B complex mitigates rotenone-induced Parkinson\u2019s disease in rats: impact on Nrf2\/HO-1, NF-kB, AMPK\/SIRT-1\/Beclin-1, AKT\/GSK-3\u03b2\/CREB\/BDNF and apoptotic pathways","volume":"186","author":"Abu-Elfotuh","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2026.124369_bb0370","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1007\/s12015-021-10259-y","article-title":"Meloxicam with filgrastim may reduce oxidative stress in hematopoietic progenitor cells during mobilization of autologous peripheral blood stem cells in patients with multiple myeloma","volume":"17","author":"Patterson","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.lfs.2026.124369_bb0375","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1007\/s12035-024-04566-x","article-title":"Molecular and behavioral neuroprotective effects of clavulanic acid and crocin in haloperidol-induced tardive dyskinesia in rats","volume":"62","author":"Shoae-Hagh","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124369_bb0380","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2007.04.007","article-title":"Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment","volume":"420","author":"Zhang","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2026.124369_bb0385","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.56.11.1559","article-title":"Influence of l-dopa and pramipexole on striatal dopamine transporter in early PD","volume":"56","author":"Guttman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2026.124369_bb0390","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.15419\/bmrat.v4i05.169","article-title":"Haloperidol induced Parkinson\u2019s disease mice model and motor-function modulation with Pyridine-3-carboxylic acid","volume":"4","author":"Saeed","year":"2017","journal-title":"Biomed. Res. Ther."},{"key":"10.1016\/j.lfs.2026.124369_bb0395","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4155\/fmc-2017-0016","article-title":"\u0391-synuclein aggregation modulation: an emerging approach for the treatment of parkinson\u2019s disease","volume":"9","author":"Singh","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.lfs.2026.124369_bb0400","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1021\/acsomega.0c03375","article-title":"Anti-parkinson\u2019s activity of tribulus terrestris via modulation of AChE, \u03b1-synuclein, TNF-\u03b1, and IL-1\u03b2","volume":"5","author":"Saleem","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.lfs.2026.124369_bb0405","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","article-title":"Plasma apolipoprotein A1 as a biomarker for Parkinson disease","volume":"74","author":"Qiang","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lfs.2026.124369_bb0410","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2026.124369_bb0415","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.4103\/0366-6999.217092","article-title":"Relationship between apolipoprotein superfamily and parkinson\u2019s disease","volume":"130","author":"Li","year":"2017","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2026.124369_bb0420","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1139\/o03-081","article-title":"Effects of ethanol and haloperidol on plasma levels of hepatic enzymes, lipid profile, and apolipoprotein in rats","volume":"82","author":"Vasconcelos","year":"2004","journal-title":"Biochem. Cell Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:10:09Z","timestamp":1778944209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526001785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":84,"alternative-id":["S0024320526001785"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124369","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valsartan promotes neuroprotection in Parkinson's disease via epigenetic modulation and activation of the ASCL1\/Nurr1 pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124369"}}